SCHEMBL28933583

SCHEMBL28933583

Clc1nc(NC2CCCC2)ncc1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAK1 Q13153 1/20 0.47
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
ULK1 O75385 1/20 0.44
ADORA1 P30542 1/20 0.44
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
PDE4A P27815 1/20 0.41
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
CTSK P43235 1/20 0.41
IGF1R P08069 1/20 0.41
CTSC P53634 1/20 0.40
CDK7 P50613 1/20 0.40
CDK9 P50750 1/20 0.40
CDK4 P11802 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1937104 0.79 MKNK1 (0.52) PAK1HDAC3HDAC1HDAC2HDAC6
SCHEMBL1937349 0.77 MKNK1 (0.50) PAK1HDAC3HDAC1HDAC2HDAC6
SCHEMBL26045352 0.76 ULK1 (0.67) PAK1ULK1ADORA1KMT2APDE4A
SCHEMBL1935467 0.75 MAPK1 (0.47) PAK1ULK1MAPK1MKNK1MKNK2
SCHEMBL5567563 0.75 ULK1 (0.65) PAK1HDAC3HDAC1HDAC2HDAC6
SCHEMBL20430301 0.75 ULK1 (0.65) PAK1HDAC3HDAC1HDAC2HDAC6
SCHEMBL20430303 0.75 ULK1 (0.65) PAK1HDAC3HDAC1HDAC2HDAC6
SCHEMBL12237657 0.74 KDM4E (0.59) PAK1HDAC3HDAC1HDAC2HDAC6
SCHEMBL5519304 0.74 CDK2 (0.50) PAK1HDAC3HDAC1HDAC2HDAC6
SCHEMBL1976634 0.73 KMT2A (0.65) KDM4EULK1ADORA1KMT2APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109206373-B Preparation process of palbociclib intermediate 5-bromo-2-chloro-4-cyclopentylamino pyrimidine 上海医药工业研究院 2022-02-15 CN disclosed